2009 European (IUSTI/WHO) guideline on the diagnosis and treatment of gonorrhoea in adults

International Journal of STD and AIDS

Volumn 20, Issue 7, 2009, Pages 453-457

  Bignell, C ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Antimicrobial treatment; European clinical guideline; Gonorrhoea

Indexed keywords

AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFIXIME; CEFODIZIME; CEFOTAXIME; CEFPODOXIME; CEFTRIAXONE; CEFUROXIME AXETIL; CIPROFLOXACIN; DOXYCYCLINE; OFLOXACIN; PENICILLIN G; SPECTINOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BREAST FEEDING; CLINICAL FEATURE; CLINICAL TRIAL; DRUG HYPERSENSITIVITY; EPIDIDYMITIS; EYE LAVAGE; FOLLOW UP; GONORRHEA; HUMAN; INCIDENCE; MICROSCOPY; MIXED INFECTION; NEISSERIA GONORRHOEAE; NEWBORN OPHTHALMIA; NUCLEIC ACID AMPLIFICATION; ORCHITIS; PHARYNGEAL GONORRHEA; PHARYNGEAL GONORRHOEA; PHARYNGITIS; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; SINGLE DRUG DOSE; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; FEMALE; GONORRHEA; HUMANS; MALE; NEISSERIA GONORRHOEAE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; YOUNG ADULT;

EID: 67650120398     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2009.009160     Document Type: Review

References (35)

1. GRASP Steering Group. The Gonococcal Resistance to Antimicrobials Programme (GRASP) Year 2007 report. London: Health Protection Agency 2008. (www.hpa.org.uk/infections/topics-az/hiv-and-sti/sti-gonorrhoea/ publications/GRASP-2008-Annual-Report.pdf)
2. Risley CL, Ward H, Choudhury B, Bishop CJ, Fenton KA, Spratt BG, et al. Geographical and demographic clustering of gonorrhoea in London. Sex Transm Infect 2007;83:481-487 (Pubitemid 350043742)
3. Hook EW III, Handsfield H. Gonococcal infections in the adult. Chapter 32 in Holmes KK, Mårdh PA, Sparling PF, et al. (eds)., Sexually Transmitted Diseases. New York: McGraw-Hill, 1999
4. Sherrard J, Barlow D. Gonorrhoea in men: clinical and diagnostic aspects. Genitourin Med 1996;72:422-426 (Pubitemid 27019076)
5. Lewis DA, Bond M, Butt KD, Smith CP, Shafi MS, Murphy SM. A one-year survey of gonococcal infection seen in the genitourinary medicine department of a London district general hospital. Int J STD AIDS 1999;10:588-594 (Pubitemid 29414599)
6. Barlow D, Phillips I. Gonorrhoea in women: diagnostic, clinical and laboratory aspects. Lancet 1978;i:761-764 (Pubitemid 8303179)
7. Kent CK, Chaw JK, Wong W, et al. Pevalence of rectal, urethral and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California 2003. Clin Infect Dis 2005;41:67-74
8. Jephcott AE. Microbiological diagnosis of gonorrhoea. Genitourin Med 1997;73:245-252
9. Cook RL, Hutchison SL, Østergaard L, Braithwaite RS, Ness RB. Systematic review: non-invasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med 2005;142:914-925
10. Van Dyck E, Ieven M, Pattyn S, Van Damme L, Laga M. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture and three nucleic acid amplification tests. J Clin Microbiol 2001;39:1751-1756 (Pubitemid 32417015)
11. Ison C. GC NAATs: is the time right? Sex Transm Infect 2006;82:515
12. HPS, Scottish Bacterial STIs Reference Laboratory. Guidance on the Introduction of molecular testing for Neisseria gonorrhoeae in Diagnostic Laboratories. Available at: http://www.documents.hps.scot.nhs.uk/labs/ sngrl/naata-2007-08.pdf (last accessed 1 August 2007)
13. Smith DW, Tapsall JW, Lum G. Guidelines for the use and interpretation of nucleic acid detection tests for Neisseria gonorrhoeae in Australia: a position paper on behalf of the Public Health Laboratory Network. Commun Dis Intell 2005;29:358-365
14. Page-Shafer K, Graves A, Kent C, Bals JE, Zapitz VM, Klausner JD. Increased sensitivity of DNA amplification testing for the detection of pharyngeal gonrrhoea in men who have sex with men. Clin Infect Dis 2002;34:173-176 (Pubitemid 34028348)
15. McNally LP, Templeton DJ, Jin F, et al. Low positive predictive value of a nucleic acid amplification test for nongenital Neisseria gonorrhoeae infection in homosexual men. Clin Infect Dis 2008;47:e25-7
16. Center for Disease Control and prevention. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections - 2002. MMWR 2002;51: No. RR-15
17. Ghanem M, Radcliffe K, Allan P. The role of urethral samples in the diagnosis of gonorrhoea in women. Int J STD AIDS 2004;15:45-47 (Pubitemid 38096129)
18. Martin IMC, Hoffman S, Ison CA. European surveillance of sexually transmitted infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe. J Antimicrob Chemother 2006;58:587-593 (Pubitemid 44288123)
19. Herida M, Desenclos J-D, Martin IMC, Goulet V, Laurent E, Sednaoui P. Increase of Neisseria gonorrhoeae ciprofloxacin resistance in France in 2001-2003. Sex Transm Dis 2006;33:6-7
20. Tapsall JW. Antibiotic resistance in Neisseria gonorrhoeae. Clin Infect Dis 2005;41:S263-8
21. Newman LM, Moran JS, Workowski KA. Update on the management of gonorrhoea in adults in the United States. Clin Infect Dis 2007;44:S84-101 (Pubitemid 46452042)
22. Tapsall J. Current concepts in the management of gonorrhoea. Expert Opin Pharmacother 2002;3:147-157
23. Health Protection Agency. Health Protection Report 2008;2:No 14 (4 April)
24. Tapsall JW, Schultz TR, Limnios EA, Donovan B, Lum G, Mulhall BP. Failure of azithromycin therapy in gonorrhoea and discorrelation with laboratory parameters. Sex Transm Dis 1998;25:505-508 (Pubitemid 28553604)
25. Young H, Moyes A, McMillan A. Azithromycin and erythromycin resistant Neisseria gonorrhoeae following treatment with azithromycin. Int J STD AIDS 1997;8:299-302 (Pubitemid 27202413)
26. Moran JS, Levine WC. Drugs of choice in the treatment of uncomplicated gonococcal infection. Clin Infect Dis 1995;20 (Suppl. 1):S47-65
27. British Association for Sexual Health and HIV. CEG Guideline: Management of gonorrhoea in adults 2005. (www.bashh.org/guidelines/ceguidelines. htm)
28. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2006. Gonorrhoea. MMWR 2006;55 (No. RR-11): (www.cdc.gov/std/treatment)
29. Novak E, Paxton LM, Tubbs HJ, Turner LF, Keck CW, Yatsu J. Orally administered cefpodoxime proxetil for the treatment of uncomplicated gonococcal urethritis in males: a dose-response study. Antimicrob Agents Chemother 1992;36:1764-1765
30. Ison CA, Mouton JW, Jones K, Fenton KA, Livermore DA. Which cephalosporin for gonorrhoea? Sex Transm Infect 2004;80:386-388
31. Moran JS. Ciprofloxacin for gonorrhea - 250 mg or 500 mg? Sex Transm Dis 1996;23:165-167
32. Handsfield HH, Dalu ZA, Martin DH, et al. Multicenter trial of single-dose azithromycin vs ceftriaxone in the treatment of uncomplicated gonorrhoea. Sex Transm Dis 1994;21:107-111 (Pubitemid 24127677)
33. Moran JS. Treating uncomplicated Neisseria gonorrhoeae infections: is the anatomic site of infection important? Sex Transm Dis 1995;22:39-47
34. Ramus RM, Sheffield JS, Mayfield JA, Wendel GD. A randomised trial that compared oral cefixime and intramuscular ceftriaxone for the treatment of gonorrhoea in pregnancy. Am J Obstet Gynecol 2001;185:629-632 (Pubitemid 32862551)
35. Thompson SE. Treatment of disseminated gonococcal infections. Sex Transm Dis 1979;6 (Suppl. 1):181-184